AlgiPharma AS is a clinical stage pharmaceutical company founded in August 2006, based on research and development carried out by FMC BioPolymer AS and the Biopolymer Foundation at the Norwegian University of Science and Technology in Trondheim, Norway. AlgiPharma’s aim is to address unmet medical needs, fighting diseases effectively through its innovative alginate oligomer technologies, by developing products and therapies to market or license to suitable partners. AlgiPharma AS owns or licenses all relevant patents upon which the technology platform and products are developed. AlgiPharma is supported by national and international research programs and grants, and collaborates with a network of key opinion leaders, highly recognized academic institutions, research and patient organizations in Europe and USA. AlgiPharma is a privately owned company registered and domiciled in Norway.

Parion Sciences is a development stage company dedicated to research, development, and commercialization of treatments to restore patient’s innate mucosal surface defenses. In the eye and in the lung, our layer of protective mucus plays an important role in keeping our bodies healthy. Sometimes though, either through genetics, aging or environmental stimulus, our innate mucosal defense system can become compromised. Parion’s science driven technologies target respiratory and ocular diseases in which the patient’s ability to protect their mucosal surfaces is compromised

The Board of Regents of The University of Texas System, a subsidiary of The University of Texas at Austin, is an American company located in Austin, TX. The firm oversees college activities.

Tepha is a medical device firm pursuing the development and commercialization of innovative products based on the company's proprietary biomaterial technology. The technology provides a new class of absorbable biomaterials, known as polyhydroxyalkanoates , which may be tailored to meet unmet needs for medical devices in multiple fields. Tepha's novel, biosynthetically produced materials offer superior performance in flexibility, elasticity, and biocompatibility; and, for its fiber-based products, excellent tensile strength and strength retention.

Melinta Subsidiary Corp. develops and markets pharmaceutical products for the treatment of life-threatening infections. It also develops novel classes of antibiotics to treat the multi- and extremely-drug-resistant pathogens for which there are few to no options, known collectively as ESKAPE pathogens. The company was founded by John N. Abelson, Harry F. Noller, Susan Froshauer, Harry H. Penner, Jr., William L. Jorgensen, Thomas A. Steitz, and Peter Moore in October 2000 and is headquartered in New Haven, CT.

Part of Bicycle Therapeutics Plc, BicycleTx Ltd. is a British company located in Babraham. The firm provides business support services. It was founded in 2017.

Fidia Farmaceutici SpA manufactures pharmaceutical products. The firm's platform technology level is the chemical modification, development, and manufacturing of state-of-the-art pharmaceuticals and medical devices based on hyaluronan covering therapeutic categories. The company was founded in 1946 and is headquartered in Abano Terme, Italy.

B·R·A·H·M·S explores, develops and produces new diagnostic test procedures to improve the diagnosis, and thereby the treatment, of life-threatening illnesses. This takes place with over 400 employees, on the basis of their own patented biomarkers, and leads to medically and economically superior diagnostic insights for patients and medical professionals. B·R·A·H·M·S products reach customers in over 65 countries around the world and are leaders in their specialized markets.

Paul GmbH & Co. KG, a subsidiary of Ruppel GmbH & Co. KG, is a German company located in Steinau an der Strasse. The firm manufactures screening machines. It was founded in 1953 by Hans Paul, Hans Arnold and Werner Seyfert. Peter W. Ruppel and Garvin Ruppel are the current co-CEOs of the firm. Paul GmbH & Co. KG was acquired by Ruppel GmbH & Co. KG on February 16, 2021.

Dynavax is a commercial stage biopharmaceutical company developing and commercializing novel vaccines. The Company's first commercial product, HEPLISAV-B® [Hepatitis B Vaccine (Recombinant), Adjuvanted], is approved in the U.S. and the European Union for prevention of infection caused by all known subtypes of hepatitis B virus in adults age 18 years and older. Dynavax is also advancing CpG 1018TM adjuvant as a premier vaccine adjuvant through research collaborations and partnerships. Current collaborations are focused on adjuvanted vaccines for COVID-19, pertussis and universal influenza.

Part of Catalent, Inc., Columbia Laboratories (Bermuda) Ltd. is a Bermudian company located in Hamilton. The firm manufactures pharmaceutical products.

B. Braun Melsungen AG manufactures and distributes pharmaceutical products and medical equipment. Its products are used in the treatment of degenerative spinal diseases, diabetes management, nutritional therapy, extracorporeal blood treatment, laparoscopy, neurosurgery, wound management, and urology. The company was founded on June 23, 1839 and is headquartered in Melsungen, Germany.

SCA Hygiene Products AB engages in the development, manufacture, and sale of textile goods, clothing products, medical, and hygiene articles. The firm also carries out data processing activities. The company was founded on January 21, 1907 and is headquartered in Mölndal, Sweden.

The Board of Trustees of the University of Illinois, part of University of Illinois, is a company headquartered in Urbana, IL, that trusts Except Educational Religious.

Novus International, Inc., headquartered in metro St. Louis, Missouri, U.S., is an animal health and nutrition company. It serves customers ranging from animal nutritionists to veterinarians, to individual animal owners. Novus is privately owned by Mitsui & Co. (U.S.), and Nippon Soda Co., Ltd. and operates in over 90 countries. Novus's products include amino acids, organic trace minerals, feed preservatives, and various nutrition and health products.

Excelsior Medical was founded in 1989. In 1990, we introduced the PharmAssist dispensing pump to reconstitute powdered drugs into liquid form. In 1995, they developed and introduced the ESP syringe pump to complement our PharmAssist dispensing system. In 1997, they introduced Syrex prefilled catheter flush syringes and have grown over the years to become one of the largest manufacturers of prefilled flush syringes in the U.S. In 2007, they introduced their new ZR family of syringes that were designed specifically to minimize syringe related reflux and begin their focus on developing products for intra-luminal catheter care. They are also one of the very few manufacturers that 100% terminally sterilizes all its prefilled syringe products.

St. Jude Medical, Inc. was an American global medical device company headquartered in Little Canada, Minnesota, U.S., a suburb of Saint Paul. The company had more than 20 principal operations and manufacturing facilities worldwide with products sold in more than 100 countries. Its major markets include the United States, Europe, Latin America and Asia-Pacific. The company was named after Jude the Apostle, the patron saint of lost causes.

Beth Israel Deaconess Medical Center (BIDMC) in Boston, Massachusetts is a teaching hospital of Harvard Medical School. It was formed out of the 1996 merger of Beth Israel Hospital (founded in 1916) and New England Deaconess Hospital (founded in 1896). Among independent teaching hospitals, Beth Israel Deaconess Medical Center consistently ranks in the top three recipients of biomedical research funding from the National Institutes of Health. Research funding totals nearly $200 million annually. BIDMC researchers run more than 850 active sponsored projects and 200 clinical trials. The Harvard-Thorndike General Clinical Research Center, the oldest clinical research laboratory in the United States, has been located on this site since 1973.